Theravance Biopharma (TBPH) Tops Q3 EPS by 7c

Theravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($0.48), $0.07 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $14.69 million.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c